794 related articles for article (PubMed ID: 27008872)
1. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
Fauchier T; Hasseine L; Gari-Toussaint M; Casanova V; Marty PM; Pomares C
J Clin Microbiol; 2016 Jun; 54(6):1487-1495. PubMed ID: 27008872
[TBL] [Abstract][Full Text] [Related]
2. Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.
Louis M; Guitard J; Jodar M; Ancelle T; Magne D; Lascols O; Hennequin C
J Clin Microbiol; 2015 Dec; 53(12):3870-5. PubMed ID: 26468505
[TBL] [Abstract][Full Text] [Related]
3. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.
Montesinos I; Brancart F; Schepers K; Jacobs F; Denis O; Delforge ML
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):143-7. PubMed ID: 25801778
[TBL] [Abstract][Full Text] [Related]
5. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
[TBL] [Abstract][Full Text] [Related]
7. A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients.
Tia T; Putaporntip C; Kosuwin R; Kongpolprom N; Kawkitinarong K; Jongwutiwes S
Clin Microbiol Infect; 2012 Jun; 18(6):598-603. PubMed ID: 21951463
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients - Experience from a tertiary care center, India.
S D; S TD; Gupta R; Varughese S; Varghese GM; George B; Michael JS
J Mycol Med; 2022 May; 32(2):101241. PubMed ID: 34999296
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
[TBL] [Abstract][Full Text] [Related]
10. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
Matsumura Y; Ito Y; Iinuma Y; Yasuma K; Yamamoto M; Matsushima A; Nagao M; Takakura S; Ichiyama S
Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
[TBL] [Abstract][Full Text] [Related]
11. Ability of quantitative PCR to discriminate
Perret T; Kritikos A; Hauser PM; Guiver M; Coste AT; Jaton K; Lamoth F
J Med Microbiol; 2020 May; 69(5):705-711. PubMed ID: 32369002
[No Abstract] [Full Text] [Related]
12. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
[TBL] [Abstract][Full Text] [Related]
13. Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.
Sasso M; Chastang-Dumas E; Bastide S; Alonso S; Lechiche C; Bourgeois N; Lachaud L
J Clin Microbiol; 2016 Mar; 54(3):625-30. PubMed ID: 26719435
[TBL] [Abstract][Full Text] [Related]
14. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.
Mühlethaler K; Bögli-Stuber K; Wasmer S; von Garnier C; Dumont P; Rauch A; Mühlemann K; Garzoni C
Eur Respir J; 2012 Apr; 39(4):971-8. PubMed ID: 21920890
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.
Chumpitazi BF; Flori P; Kern JB; Brenier-Pinchart MP; Hincky-Vitrat V; Brion JP; Thiebaut-Bertrand A; Minet C; Maubon D; Pelloux H
Med Mycol; 2011 Oct; 49(7):704-13. PubMed ID: 21417683
[TBL] [Abstract][Full Text] [Related]
16. High Diagnostic Value of a New Real-Time Pneumocystis PCR from Bronchoalveolar Lavage in a Real-Life Clinical Setting.
Unnewehr M; Friederichs H; Bartsch P; Schaaf B
Respiration; 2016; 92(3):144-9. PubMed ID: 27595408
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
Rogina P; Skvarc M
Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients.
Guegan H; Robert-Gangneux F
Curr Opin Infect Dis; 2019 Aug; 32(4):314-321. PubMed ID: 31107250
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
Kilic A; Elliott S; Hester L; Palavecino E
J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
[TBL] [Abstract][Full Text] [Related]
20. Comparative Evaluation Between the RealStar
Huh HJ; Lim KR; Ki CS; Huh K; Shim HJ; Song DJ; Kim YJ; Chung DR; Lee NY
Ann Lab Med; 2019 Mar; 39(2):176-182. PubMed ID: 30430780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
